BEESE FULMER INVESTMENT MANAGEMENT, INC.
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 911274
CANTON, OH
Position in BMRN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$357,396
-$72,266 QoQ
Shares Held
6,246
-17.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#366
of 561 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BEESE FULMER INVESTMENT MANAGEMENT, INC. holds $744,305 across 2 Biotechnology names. BMRN ranks #2 (48.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
7,111 | $386,909 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
6,246 | $357,396 |
All Filings in BMRN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $357,396 | 6,246 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $429,662 | 7,606 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $374,171 | 6,296 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||